What they found: Dose-dependent stimulation of type II collagen (up to 2.5 baseline at 100 nM) Stimulation of aggrecan (up to 1.8 baseline) Inhibition of MMP-13 by ~40 % Partial protection against IL-1-induced matrix degradation Why it matters: It opened a completely new research area for AOD-9604 beyond lipolysis
Reduction of total fluid volume occurs through the inhibition of sodium reabsorption in the distal tubules, which causes increased excretion of sodium, water, potassium, and hydrogen
Common Protocol: MK-677: 12.525 mg daily, oral, taken at night BPC-157: 250500 mcg daily, subcutaneous Cycle: 812 weeks for MK-677
Neck & Cervical Spasms Cervical spasms cause a range from whiplash and herniated cervical discs to stress, MS-related neck stiffness, and poor sleep position
A dietary cause is often managed with daily tablets, or an injection roughly twice a year